Oxford-AstraZeneca Covid vaccine error: What is the way forward for Covishield in India
There could be two potential reasons behind this mistake committed by the Oxford-AstraZeneca. Oxford-AstraZeneca’s Covid-19 vaccine candidate AZD1222 showed an efficacy rate up to 90 per cent for half dose in November. However, later it was revealed that the positive findings came out due to a mistake. In this article we are looking into why … Read more